APR Applied Pharma Research SA-医療機器分野:企業M&A・提携分析

◆英語タイトル:APR Applied Pharma Research SA - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011241
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
APR Applied Pharma Research SA (APR) is a healthcare company which focuses on the development and licenses of healthcare products for rare therapeutic areas. The company offers consumer health products, prescription healthcare products and therapeutic products. APR’s product pipeline portfolio includes nexodyn, gemiax, exelya and APR 1204, among others. It develops products for various therapeutic areas such as cancer, dermatology, genetic metabolic diseases, pain management and tissue transplantation, among others. APR also provides services such as oral formulations, tropical formulations and analytical services. The company research, develops, and licenses technology driven and clinically proven prescription pharmaceuticals. APR is headquartered in Balerna, Switzerland.

APR Applied Pharma Research SA – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
APR Applied Pharma Research SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
APR Applied Pharma Research SA, Medical Equipment Deals By Type, 2011 to YTD 2017 6
APR Applied Pharma Research SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
APR Applied Pharma Research SA, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
APR Applied Pharma Research SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
APR Applied Pharma Research SA, Medical Equipment, Deal Details 10
Venture Financing 10
APR Applied Pharma Research Raises Funds through Venture Financing 10
Private Equity 11
HBM Partners Acquires Minority Stake in APR Applied Pharma 11
Partnerships 12
APR Applied Pharma Research and AT Technologies Enter into Distribution Partnership 12
APR Applied Pharma Research Enter into Distribution Agreement with Aghraas-Cigalah 13
APR Applied Pharma Research SA – Key Competitors 14
APR Applied Pharma Research SA – Key Employees 15
APR Applied Pharma Research SA – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Product News 17
May 25, 2017: APR Applied Pharma Research at the 9th ChinaBio Partnering Forum: Bringing Swiss Made Innovations and Science Driven Technologies to Strengthen Its Presence in the Chinese Market 17
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
APR Applied Pharma Research SA, Medical Equipment, Key Facts 2
APR Applied Pharma Research SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
APR Applied Pharma Research SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
APR Applied Pharma Research SA, Medical Equipment Deals By Type, 2011 to YTD 2017 6
APR Applied Pharma Research SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
APR Applied Pharma Research SA, Deals By Market, 2011 to YTD 2017 8
APR Applied Pharma Research SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
APR Applied Pharma Research Raises Funds through Venture Financing 10
HBM Partners Acquires Minority Stake in APR Applied Pharma 11
APR Applied Pharma Research and AT Technologies Enter into Distribution Partnership 12
APR Applied Pharma Research Enter into Distribution Agreement with Aghraas-Cigalah 13
APR Applied Pharma Research SA, Key Competitors 14
APR Applied Pharma Research SA, Key Employees 15

★海外企業調査レポート[APR Applied Pharma Research SA-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EuroSibEnergo Plc:企業の戦略的SWOT分析
    EuroSibEnergo Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Opsona Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Opsona Therapeutics Ltd (Opsona) is a biopharmaceutical company that conducts research, develops and commercializes new treatment for the autoimmune and inflammatory diseases and cancers. The company's OPN-305 is a humanized antibody used to reduce pro-inflammatory cytokine production that i …
  • Teekay Corp (TK):石油・ガス:M&Aディール及び事業提携情報
    Summary Teekay Corp (Teekay) is a provider of marine transportation services to oil and gas industry. The company transports crude oil, liquefied natural gas (LNG), liquefied petroleum gas (LPG) and other petroleum products. It also offers offshore oil production, storage and offloading services. Te …
  • Tethys Oil AB (TETY):企業の財務・戦略的SWOT分析
    Summary Tethys Oil AB (Tethys Oil) is an upstream oil and gas company that offers exploration, development and production of oil and natural gas reserves. The company holds onshore exploration licences in Lithuania and France. Tethys Oil holds Gargzdai license, Rietavas license and Raseiniai license …
  • Pacific Drilling SA (PACD):企業の財務・戦略的SWOT分析
    Summary Pacific Drilling SA (Pacific Drilling) is an offshore drilling company that offers ultra deepwater drilling services to the oil and natural gas industry. The company provides contract services for floating rig drilling in ultra deepwater through its drill ships. It rents its drilling rigs, r …
  • Society for Worldwide Interbank Financial Telecommunication:企業の戦略的SWOT分析
    Society for Worldwide Interbank Financial Telecommunication - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, k …
  • Corvidia Therapeutics:製薬・医療:M&Aディール及び事業提携情報
    Summary Corvidia Therapeutics is a developer of cardiovascular therapies. The company develops cardiovascular therapies leveraging functional genomics. Its pipeline programs are targeted at identifying patients with unique sensitivity to specific biologic pathways, which allows the development of th …
  • Getinge AB (GETI B):企業の財務・戦略的SWOT分析
    Getinge AB (GETI B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Enka Power:企業の戦略的SWOT分析
    Enka Power - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • EnerNOC, Inc.-エネルギー分野:企業M&A・提携分析
    Summary EnerNOC, Inc. (EnerNOC), formerly EnerNOC, LLC, is a provider of energy intelligence software (EIS) and demand response solutions. The company’s EIS offers enterprise customers with Software-as-a-Service (SaaS) solutions with various areas of functionalities. It offers SaaS solutions to mana …
  • MediPlast AB-医療機器分野:企業M&A・提携分析
    Summary MediPlast AB (MediPlast) is a medical device company that offers surgery equipment. The company manufactures, markets, distributes, and sells medical technical equipment and disposable products. Its products include swabs and balls, conforming and support bandages, cohesive bandages, compres …
  • The Reject Shop Limited (TRS):企業の財務・戦略的SWOT分析
    The Reject Shop Limited (TRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Mitsubishi Logistics Corporation
    Mitsubishi Logistics Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Logistics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Chiome Bioscience Inc (4583)-製薬・医療分野:企業M&A・提携分析
    Summary Chiome Bioscience Inc (Chiome Bioscience) is a healthcare service company that offers research and development of therapies. The company research and develops antibody drugs for the treatment of autoimmune and inflammatory diseases. Its ADLib system is a monoclonal antibody generating system …
  • KeyCorp (KEY)-エネルギー分野:企業M&A・提携分析
    Summary KeyCorp (KeyCorp) is a financial holding company that offers a range of retail and commercial banking, consumer finance, commercial mortgage and special servicing, commercial leasing, investment management, and investment banking products and services to individuals, corporate, and instituti …
  • Newmont Corp:企業の戦略・SWOT・財務分析
    Newmont Corp - Strategy, SWOT and Corporate Finance Report Summary Newmont Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Grand Haven Board of Light and Power:企業の戦略的SWOT分析
    Grand Haven Board of Light and Power - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Ophthotech Corp (OPHT):製薬・医療:M&Aディール及び事業提携情報
    Summary Ophthotech Corp (Ophthotech) is a biopharmaceutical company that offers novel therapeutics to treat diseases of the back of the eye for age-related macular degeneration. The company’s products include Zimura, an anti-complemente is a central component of the complement cascade that is suppos …
  • Zavante Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Zavante Therapeutics Inc (Zavante), formerly SG Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops novel therapies for the treatment of infectious diseases such as due to multi-drug resistant (MDR) bacteria. The company offers drugs for the treatment of diseases …
  • Leap Therapeutics Inc (LPTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Leap Therapeutics Inc (Leap Therapeutics), formerly HealthCare Pharmaceuticals Inc, is a clinical-stage biopharmaceutical company that develops novel therapeutics to treat patients with cancer. The company’s pipeline products include DKN-01, a humanized monoclonal antibody that targets the D …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆